We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$4.25B
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter
Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
(+34%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LGN
Legence Corp
LGN
|
+$53.3M |
| 2 |
Sensient Technologies
SXT
|
+$43.9M |
| 3 |
InterDigital
IDCC
|
+$35.5M |
| 4 |
Axcelis
ACLS
|
+$34.7M |
| 5 |
Terex
TEX
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$137M |
| 2 |
Credo Technology Group
CRDO
|
+$94.7M |
| 3 |
TTM Technologies
TTMI
|
+$85.3M |
| 4 |
Fabrinet
FN
|
+$68.7M |
| 5 |
Sterling Infrastructure
STRL
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Industrials | 24.1% |
| 3 | Healthcare | 21.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 9.02% |
Similar funds
AP
QWP
HMC
SCA
MA
TFM
IAA
CAM
Emerald Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
- Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
- Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
- Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
- Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
- Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.